Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT01747798 · COMPLETED

Trial details

NCT number: NCT01747798
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent Fallopian Tube Cancer Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer

Start date: 2012-11-02
Primary completion: 2014-01-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.